Abbott Laboratories share price logo

Abbott Laboratories Share Price

NYSE: ABT

Large Cap

$125.02

-0.38

(-0.30%)

as on

Abbott Laboratories Stock Performance

as on December 6, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $124.64
    $126.05
    downward going graph

    0.30%

    Downside

    0.82%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $110.86
    $141.23
    downward going graph

    11.33%

    Downside

    12.97%

    Upside

    downward going graph

Abbott Laboratories share price movements today

Previous Close
$125.40
Open
$125.66
Volume
2.7M
Day's Low - High
$124.64 - $126.05
52 Week Low - High
$110.86 - $141.23

Abbott Laboratories Historical Returns

1 Month Return
+ 0.1 %
3 Month Return
-5.91 %
1 Year Return
+ 8.2 %
3 Year Return
+ 20.43 %
5 Year Return
+ 15.92 %

Abbott Laboratories Stock Fundamentals & Key Indicators

Check Abbott Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$218.3B

EPS (TTM)

5.1545

Dividend Yield

1.90%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

15.75

Industry PE ratio

19.200384615384614

PEG Ratio

4.1675

EBITDA

11.7B

Revenue (TTM)

43.8B

Profit Margin

31.88%

Return On Equity TTM

30.62%

Abbott Laboratories Stock Valuation

Track how Abbott Laboratories P/E has moved over time to understand its valuation trends.

Abbott Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (18.93x)

September 30, 2022

Today (15.75x)

December 6, 2025

Industry (19.20x)

December 6, 2025

Highest (30.52x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 15.75x

Abbott Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abbott Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abbott Laboratories image
Abbott Laboratories
BUY$218.3B15.92%15.7531.88%
Johnson & Johnson image
Johnson & Johnson
BUY$487.8B34.38%19.5627.26%
Pfizer Inc. image
Pfizer Inc.
HOLD$146.1B-35.47%14.9415.65%

Stock Returns calculator for Abbott Laboratories Stock including INR - Dollar returns

The Abbott Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abbott Laboratories investment value today

Current value as on today

₹1,14,088

Returns

₹14,088

(+14.09%)

Returns from Abbott Laboratories Stock

₹8,149 (+8.15%)

Dollar Returns*

₹5,939 (+5.94%)

Analyst Recommendation on Abbott Laboratories Stock

Based on 29 analysts

BUY

75.86%

Buy

24.14%

Hold

0.00%

Sell

Based on 29 analysts, 75.86% of analysts recommend a 'BUY' rating for Abbott Laboratories. Average target price of $144.43

Abbott Laboratories Share Price Target

Get share price movements and forecasts by analysts on Abbott Laboratories.

What analysts predicted

13.44%UPSIDE

Target Price

$144.43

Current Price

$125.02

Analyzed by

29 Analysts

Target

$144.43

Abbott Laboratories target price $144.43, a slight upside of 13.44% compared to current price of $125.02. According to 29 analysts rating.

Abbott Laboratories Stock’s Investor Sentiment and Interest

Investment in Abbott Laboratories Shares on INDmoney has dropped by -41.70% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-41.70% versus previous 30 day period

Search interest for Abbott Laboratories Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Abbott Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
9,978
10,143
10,241
9,964
10,377
10,635
10,974
10,358
11,142
11,369
Gross Profit
4,945
5,034
5,258
5,022
5,305
5,426
5,598
5,444
6,288
6,338
Operating Income
1,511
1,678
1,864
1,385
1,686
1,818
1,990
1,688
2,052
2,030
EBITDA
2,589
2,643
2,843
2,358
2,580
2,907
2,989
2,668
3,048
3,015
Interest Expense
153
148
235
117
168
166
152
134
121
44
Depreciation
498
496
813
805
805
801
807
756
777
791
Income Before Tax
1,636
1,671
1,795
1,436
1,607
1,940
2,030
1,778
2,150
2,180
Income Tax Expense
261
235
201
211
305
294
-7,199
453
371
536
Net Income
1,375
1,436
1,594
1,225
1,302
1,646
9,229
1,325
1,779
1,644
Net Profit Margin
13.78%
14.16%
15.56%
12.29%
12.55%
15.48%
84.10%
12.79%
15.97%
14.46%

Abbott Laboratories Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
20,405
20,853
27,390
30,578
31,904
34,608
43,075
43,653
40,109
41,950
Gross Profit
10,960
11,244
13,066
15,823
16,693
17,377
23,214
22,323
20,037
21,325
Operating Income
2,949
3,249
1,972
3,844
4,591
5,291
9,200
8,362
6,435
6,825
EBITDA
4,833
3,070
6,132
6,880
7,909
9,003
12,159
11,888
10,605
10,834
Interest Expense
178
304
880
729
818
708
410
315
698
603
Depreciation
-
-
3,021
3,278
3,014
3,327
2,047
2,013
3,237
3,218
Income Before Tax
3,183
1,413
2,231
2,873
4,077
4,968
8,211
8,306
6,664
7,013
Income Tax Expense
577
350
1,878
539
390
497
1,140
1,373
941
-6,389
Net Income
4,423
1,400
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
Net Profit Margin
21.68%
6.71%
1.74%
7.74%
11.56%
12.99%
16.42%
15.88%
14.27%
31.95%

Abbott Laboratories Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
1,436
1,594
1,225
1,302
1,646
9,229
1,325
1,779
1,644
Operating Cash Flow
1,877
3,038
1,025
1,960
2,705
2,868
1,417
2,047
2,787
Investing Cash Flow
-634
-824
-425
-453
-594
-866
-470
-582
-457
Financing Cash Flow
-2,340
-2,052
-1,176
-791
-1,576
-1,861
-2,055
-1,097
-1,760
Change in Cash
-1,126
187
-612
703
571
58
-1,084
419
560

Abbott Laboratories Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
1,375
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
Operating Cash Flow
3,203
5,570
6,300
6,136
7,901
10,533
9,581
7,261
8,558
Investing Cash Flow
-248
-9,618
-1,356
-1,815
-2,215
-2,008
-1,740
-3,133
-2,338
Financing Cash Flow
11,147
-5,281
-10,391
-4,289
-2,779
-5,494
-7,636
-7,091
-5,404
Change in Cash
13,619
-9,213
-5,563
16
2,978
2,961
83
-2,986
720

Mutual Funds that own Abbott Laboratories Stock

Check out the Mutual Funds with significant holdings in Abbott Laboratories.

Global Institutional Holdings in Abbott Laboratories

Funds
Holdings
Vanguard Group Inc
9.93%
BlackRock Inc
8.12%
State Street Corp
4.5%
Capital Research & Mgmt Co - Division 3
3.46%
Capital Research Global Investors
2.4%
See all

Abbott Laboratories News & Key Events

  • img

    Today's Timeline - 05 December

    Fri, 10:06 PM

    -

    FDA issues safety alert for Abbott glucose sensors linked to 736 injuries and 7 deaths due to inaccurate readings.

    Fri, 10:40 PM

    -

    Discounted Cash Flow analysis suggests Abbott Laboratories may be overvalued by 72.1%, despite strong growth in devices and diagnostics.

Insights on Abbott Laboratories

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Abbott Laboratories has shown positive revenue growth over the last three quarters. The revenue has increased from $10.35 billion to $11.36 billion, with an average increase of 4.5% per quarter.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Johnson & Johnson has given 35.2% return, outperforming this stock by 27.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Abbott Laboratories has experienced a decline in its net profit over the last two quarters. In the most recent quarter, the net profit was $1.64 billion, down from $1.77 billion in the previous quarter. This represents an average decrease of 7.6% in net profit per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABT stock has moved down by -2.3%

About Abbott Laboratories

"Abbott Laboratories, headquartered in Chicago, Illinois, was founded in 1888 by a physician named Dr Wallace Calvin. His purpose was to improve people's well-being and help them reach their full potential at different stages of their lives. Founded as a drug formulation company, today, Abbott Laboratories is a worldwide leader in healthcare, medical devices, nutritional products, and pharmaceutical drugs. Even though it reached the shores of India a century ago, it is still regarded as one of the largest healthcare product companies. With a focus on cardiovascular, diagnostic, diabetes, and neuromodulation products, some of its popular brands include Pedialyte, Glucerna, Similac, Ensure, and iStat. Abbott opened its first international office in London in 1907, and currently operates in over 160 countries. Its growth is also a result of strategic acquisitions. Abbott’s recent acquisitions include Kalo Pharma International in 2014, which doubled its brand generic drug portfolio. It acquired Tendyne in 2015 and along with it the company’s minimally invasive mitral valve replacement therapies. Another gem in the crown is the acquisition of Alere in 2016, which gave Abbott access to the largest mail-order diabetic supplier, Arriva Medical. Along with strategic acquisitions, the company is dedicated to gaining a strong competitive advantage. With the onset of COVID-19, the company has developed various antibody tests that have been granted emergency-use authorization. According to Forbes, Abbott Laboratories' fast and low-cost testing methods have expedited the detection of COVID-19 virus. For its 2030 sustainability plan, the company is gearing up to introduce revolutionary products such as BinaxNOW, a COVID-19 test, and FreeStyle Libre, an innovative glucose monitoring device. Abbott’s future plans are centred around providing cutting-edge technologies at affordable prices to even the most vulnerable sections of society. Currently Abbott Laboratories has a market cap of $218.25 Billion. It has a P.E ratio of 15.75. The shares of Abbott Laboratories are trading at {current share price in dollars (in INR)}."
OrganisationAbbott Laboratories
Headquarters100 Abbott Park Road, North Chicago, IL, United States, 60064-6400
IndustryHealth Technology
CEOMr. Robert B. Ford
E-voting on sharesClick here to vote

Key Management of Abbott Laboratories

Name

Title

Ms. Elizabeth Cushman

Executive VP, General Counsel & Secretary

Ms. Mary K. Moreland

Executive Vice President of Human Resources

Ms. Melissa Brotz

Senior Vice President of Global Marketing & External Affairs

Mr. Robert B. Ford

Chairman of the Board, President & CEO

Mr. Daniel Gesua Sive Salvadori

Executive VP and Group President of Established Pharmaceuticals & Nutritional Products

Ms. Sabina Ewing

Senior VP of Business & Technology Services and Chief Information Officer

Mr. Michael Comilla

Vice President of Investor Relations.

Mr. Philip P. Boudreau

CFO & Executive VP of Finance

Ms. Lisa D. Earnhardt

Executive VP & Group President of Medical Devices

Erica L. Battaglia

VP and Chief Ethics & Compliance Officer

FAQs

What is Abbott Laboratories share price today?

Abbott Laboratories share price today is $125.02 as on at the close of the market. Abbott Laboratories share today touched a day high of $126.05 and a low of $124.64.

What is the 52 week high and 52 week low for Abbott Laboratories share?

Abbott Laboratories share touched a 52 week high of $141.23 on and a 52 week low of $110.86 on . Abbott Laboratories stock price today i.e. is closed at $125.02,which is 11.48% down from its 52 week high and 12.77% up from its 52 week low.

What is Abbott Laboratories's market capitalisation today?

Abbott Laboratories market capitalisation is $0.22T as on .

How to invest in Abbott Laboratories Stock (ABT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abbott Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbott Laboratories Shares that will get you 0.0120 shares as per Abbott Laboratories share price of $125.02 per share as on December 6, 2025 at 2:29 am IST.

What is the minimum amount required to buy Abbott Laboratories Stock (ABT) from India?

Indian investors can start investing in Abbott Laboratories (ABT) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Abbott Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Abbott Laboratories share’s latest price of $125.02 as on December 6, 2025 at 2:29 am IST, you will get 0.0800 shares of Abbott Laboratories. Learn more about fractional shares .

What are the returns that Abbott Laboratories has given to Indian investors in the last 5 years?

Abbott Laboratories stock has given 15.92% share price returns and 21.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?